- Report
- March 2025
- 154 Pages
Global
From €4216EUR$4,650USD£3,647GBP
- Report
- November 2024
- 111 Pages
Global
From €4216EUR$4,650USD£3,647GBP
- Report
- August 2024
- 100 Pages
Global
From €4216EUR$4,650USD£3,647GBP
- Report
- May 2025
- 180 Pages
Global
From €3214EUR$3,545USD£2,780GBP
€3571EUR$3,939USD£3,089GBP
- Report
- March 2025
- 120 Pages
Global
From €5394EUR$5,950USD£4,666GBP
- Report
- July 2025
- 245 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- July 2025
- 140 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- July 2025
- 184 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- July 2025
- 142 Pages
Global
From €5303EUR$5,850USD£4,588GBP
- Report
- April 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- April 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- March 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- March 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- February 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- February 2025
- 200 Pages
Global
From €4070EUR$4,490USD£3,521GBP
- Report
- September 2024
- 323 Pages
Global
From €4533EUR$5,000USD£3,921GBP
- Report
- March 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,804GBP
- Report
- March 2025
- 150 Pages
Global
From €4397EUR$4,850USD£3,804GBP
- Report
- December 2024
- 150 Pages
Global
From €4397EUR$4,850USD£3,804GBP
- Report
- September 2024
- 150 Pages
Global
From €4397EUR$4,850USD£3,804GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more